Jean Dinh

Clinical Pharmacogenetics Implementation Consortium Guideline for <scp>Cytochrome P450 (<i>CYP</i>)</scp><i>2D6</i> Genotype and Atomoxetine Therapy

Jacob T. Brown, Jeffrey R. Bishop, Katrin Sangkuhl et al. · Clinical Pharmacology & Therapeutics · 2019 · 197 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Potential Contribution of Cytochrome P450 2B6 to Hepatic 4-Hydroxycyclophosphamide Formation In Vitro and In Vivo

Brianne S. Raccor, Adam J. Claessens, Jean Dinh et al. · Drug Metabolism and Disposition · 2011 · 56 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Characterization of Atomoxetine Biotransformation and Implications for Development of PBPK Models for Dose Individualization in Children

Jean Dinh, Robin E. Pearce, Leon van Haandel et al. · Drug Metabolism and Disposition · 2016 · 27 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Is this the end for ranitidine? NDMA presence continues to confound

Jennifer A. Wagner, Jean Dinh, Jennifer R. Lightdale et al. · Clinical and Translational Science · 2021 · 25 citations · Full text

Medicine, Pharmacology, Toxicology +11

Ontogeny of Scaling Factors for Pediatric Physiology-Based Pharmacokinetic Modeling and Simulation: Microsomal Protein Per Gram of Liver

J. Steven Leeder, Jean Dinh, Andrea Gaedigk et al. · Drug Metabolism and Disposition · 2021 · 24 citations · Full text

Pharmacy, Pediatrics, Pharmacokinetics +17